BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 6242692)

  • 1. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma hormone assay in pregnancy.
    Branconi F; Cariati E; Cappelli G; Paladini S; Scarselli G
    Int J Biol Res Pregnancy; 1981; 2(3):146-8. PubMed ID: 6174457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 5. [The determination of human placental lactogen (HPL) for hormonal supervision in late pregnancy].
    Nieder J; Kapitza W
    Zentralbl Gynakol; 1976; 98(18):1129-36. PubMed ID: 983489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental lactogen.
    Letchworth AT
    Contrib Gynecol Obstet; 1976; 2():114-42. PubMed ID: 802077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 8. [The monitoring of risk pregnancies by E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6211052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation of placental prolactogen and E3 in the blood of pregnant women to placental grading by ultrasonography and its clinical significance].
    Wang SQ
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jul; 24(4):220-3, 252-3. PubMed ID: 2695301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and correlation of hormone levels in normal and pathologic pregnancies.
    Bartl W; Riss P; Bieglmayer C; Gring H
    Biol Res Pregnancy Perinatol; 1984; 5(4):143-8. PubMed ID: 6525387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human placentar lactogen (HPL) in the serum of pregnant women with diabetes, Rh-incompatibility, severe toxemia and twins].
    Bellmann O; Lang N
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):110-8. PubMed ID: 4198068
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal serum HPL levels in normal and complicated pregnancy as an index of placental function.
    Ylikorkala O
    Acta Obstet Gynecol Scand Suppl; 1973; 26():1-52. PubMed ID: 4522254
    [No Abstract]   [Full Text] [Related]  

  • 13. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies.
    Ronin-Walknowska E; Holmgren PA; von Schoultz B; Stigbrand T
    Gynecol Obstet Invest; 1984; 18(4):206-11. PubMed ID: 6510780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High risk pregnancies. Prognostic value and plasma levels of human chorionic somatomammotropin].
    Cohen M; Dumont M; Bertrand J
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):697-713. PubMed ID: 4196593
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity.
    Kundu N; Carmody PJ; Didolkar SM; Petersen LP
    Obstet Gynecol; 1978 Nov; 52(5):513-20. PubMed ID: 724167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of levels of chorionic somatomommotropic hormone during high risk pregnancies].
    Gaspard U; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):324-7. PubMed ID: 4681535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estriol and human placental lactogen as risk indicators in pregnancies of diabetic and hypertensive patients].
    Günter HH; Berger L; Messner U; Niesert S
    Z Geburtshilfe Neonatol; 1995; 199(4):142-7. PubMed ID: 7497015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of EPH-gestosis through the Gestosis Index and hormone determinations].
    Weber H
    Fortschr Med; 1977 Jul; 95(25):1630-34. PubMed ID: 69597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monitoring of pregnancies by hormone assays, the value of HPL estimations (author's transl)].
    Gitsch E; Janisch H; Spona J
    Wien Klin Wochenschr; 1973 Sep; 85(36):585-8. PubMed ID: 4750614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.